Molecular Diagnosis MDx Market Report 2025 (Global Edition)

Global Molecular Diagnosis MDx Market Report 2025 Market Size Split by Type (Noninvasive Prenatal Testing (NIPT), Along With The Diagnosis, Liquid Biopsy, Other Molecular Diagnostics), by Application ...

Molecular Diagnosis MDx Market Report Description

We have various report editions of Molecular Diagnosis MDx Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Molecular Diagnosis MDx Market Insights Video

Competitive Landscape of the Molecular Diagnosis MDx Market

In the competitive landscape of the Molecular Diagnosis (MDx) Market, several key players and companies contribute to the industry's growth and innovation. These companies are at the forefront of developing and commercializing molecular diagnostic tests and platforms, driving competition and technological advancements.

In December 2021, FIND (Switzerland), a global diagnostic alliance, has funded USD 21 million to speed the development, manufacturing, and marketing of low-cost, multi-pathogen molecular diagnostic platforms designed for use in decentralized settings in low- and middle-income countries. (Source: https://www.biospectrumindia.com/news/57/20251/find-invests-21m-to-develop-affordable-multi-pathogen-diagnostic-platforms.html) In October 2020, The Slovak Research and Development Agency provided funds to MultiplexX International (US) for applicable COVID-19/influenza research. The goal was to create a high-throughput, sensitive RT-qPCR assay and a quick, point-of-care RT-LAMP test to distinguish SARS-Cov-2 from influenza (Cov-INFect). (Source: https://www.multiplexdx.com/post/multiplexdx-receives-funding-for-applied-research-on-covid-influenza-from-the-slovak-research-and-development-agency-apvv-pp-covid-20-funding-call)

Top Companies Market Share in Molecular Diagnosis MDx Industry: (In no particular order of Rank)

• F. Hoffmann-La Roche Ltd (Switzerland)
• Hologic
• Inc. (U.S.)
• QIAGEN N.V. (Netherlands)
• Danaher Corporation (U.S.)
• bioMérieux S.A. (France)
• Becton
• Dickinson and Company (BD) (U.S.)
• Siemens Healthineers AG (Germany)
• DiaSorin S.p.A. (Italy)
• Abbott Laboratories (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Agilent Technologies
• Inc. (U.S.)
• Illumina
• Inc. (U.S.)
• Seegene
• Inc. (South Korea).
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Molecular Diagnosis MDx Market

Which Region Dominates the Molecular Diagnosis MDx Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. North America leads the way in technical innovation and healthcare research, with large investments in genomics, proteomics, and other molecular biology domains. This emphasis on scientific innovation and collaboration among academia, industry, and government agencies has accelerated the development of cutting-edge MDx products and platforms in the region.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Molecular Diagnosis MDx market due to several compelling reasons. ? In recent years, Asia Pacific has seen major expenditures in healthcare infrastructure, R&D, and diagnostic capacities. This expansion has been fueled by the growing burden of infectious diseases, the rising prevalence of chronic ailments, and the demand for reliable and quick diagnostic solutions throughout the region.

 

The current report Scope analyzes Molecular Diagnosis MDx Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Molecular Diagnosis MDx Market Analysis

According to Cognitive Market Research, the global Molecular Diagnosis MDx market size was estimated at USD 32514.5 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 13005.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Molecular Diagnosis MDx market with a market size of USD 10261.58 million in 2024 and is projected to grow at a CAGR of 4.1% during the forecast period. the US's significant share in the Molecular Diagnosis MDx market is a reflection of its leadership in healthcare innovation, research, and technology adoption, making it a key contributor to the growth and advancement of molecular diagnostics on a global scale.
• The Canada Molecular Diagnosis MDx market had a market share of USD 1560.70 million in 2024 and is projected to grow at a CAGR of 5.1% during the forecast period. Canada's participation in the Molecular Diagnosis MDx market adds to the global landscape of precision medicine and healthcare innovation, contributing to advancements in disease diagnosis, treatment, and patient care.
• The Mexico Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 1183.53million in 2024.

Europe Molecular Diagnosis MDx Market Analysis

According to Cognitive Market Research, the global Molecular Diagnosis MDx market size was estimated at USD 32514.5 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 9754.35 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.6% from 2024 to 2031.

• The United Kingdom Molecular Diagnosis MDx market had a market share of USD 1638.73 million in 2024 and is projected to grow at a CAGR of 5.4% during the forecast period. In the UK, Molecular Diagnosis MDx sales witness an upswing due to the demand for more targeted and effective treatment options.
• The France Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 897.40 million in 2024.
• According to Cognitive Market Research, the Germany Molecular Diagnosis MDx market size was valued at USD 1931.36 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. In Germany, Molecular Diagnosis MDx sales surged due to the need for early disease detection.
• The Italy Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 838.87 million in 2024.
• The Russia Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 3.6% during the forecast period, with a market size of USD 1511.92 million in 2024.
• The Spain Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 3.7% during the forecast period with a market size of USD 799.86 million in 2024
• The Luxembourg Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 302.38 million in 2024.
• The Portugal Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 4.4% during the forecast period, with a market size of USD 204.84 million in 2024.
• The Greece Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 4.9% during the forecast period, with a market size of USD 117.05 million in 2024.
• Rest of Europe's Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 3.3% during the forecast period, with a market size of USD 1511.92 million in 2024.

Asia Pacific Molecular Diagnosis MDx Market Analysis

According to Cognitive Market Research, the global Molecular Diagnosis MDx market size was estimated at USD 32514.5 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 7478.34 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031.

• According to Cognitive Market Research, the China Molecular Diagnosis MDx market size was valued at USD 3365.25 million in 2024 and is projected to grow at a CAGR of 7.6% during the forecast period. Molecular Diagnosis MDx sales surge in China due to increase in demand for advanced diagnostic technologies.
• The Japan Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 1032.01 million in 2024.
• The India Molecular Diagnosis MDx market had a market share of USD 897.40 million in 2024 and is projected to grow at a CAGR of 9.9% during the forecast period. In India, the Molecular Diagnosis MDx market is expanding due to the increasing burden of infectious diseases, rising prevalence of chronic conditions like cancer and diabetes, and the growing demand for personalized medicine.
• The South Korea Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 747.83 million in 2024.
• The Australia Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 7.8% during the forecast period, with a market size of USD 388.87 million in 2024.
• The South East Asia Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 9.1% during the forecast period, with a market size of USD 516.01 million in 2024.
• The Rest of Asia Pacific Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 7.9% during the forecast period, with a market size of USD 530.96 million in 2024.

South America Molecular Diagnosis MDx Market Analysis

According to Cognitive Market Research, the global Molecular Diagnosis MDx market size was estimated at USD 32514.5 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 1625.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Molecular Diagnosis MDx market size was valued at USD 695.81 million in 2024 and is projected to grow at a CAGR of 6.1% during the forecast period. Molecular Diagnosis MDx sales flourish in Brazil due to advancements in research and development.
• Argentina Molecular Diagnosis MDx market had a market share of USD 273.12 million in 2024 and is projected to grow at a CAGR of 6.4% during the forecast period. Argentina's technological advancements augment the demand to drive innovation in the logistics industry.
• Colombia Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 5.3% during the forecast period with a market size of USD 144.69 million in 2024.
• Peru Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 5.7% during the forecast period with a market size of USD 133.31 million in 2024.
• Chile Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 5.8% during the forecast period with a market size of USD 117.05 million in 2024.
• The Rest of Latin America Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 4.6% during the forecast period, with a market size of USD 261.74 million in 2024.

Middle East Molecular Diagnosis MDx Market Analysis

According to Cognitive Market Research, the global Molecular Diagnosis MDx market size was estimated at USD 32514.5 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 650.29 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.

• The GCC Countries Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 6.6% during the forecast period with a market size of USD 278.32 million in 2024. Molecular Diagnosis MDx sales flourish due to growing demand for personalized medicine
• The Egypt Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 6.1% during the forecast period, with a market size of USD 68.28 million in 2024.
• The South Africa Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 102.75 million in 2024. Molecular Diagnosis MDx sales flourish in South Africa due to rising prevalence of chronic conditions like cancer and diabetes.
• The Turkey Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 5.3% during the forecast period, with a market size of USD 55.92 million in 2024.
• The Nigeria Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 4.9% during the forecast period, with a market size of USD 68.28 million in 2024.
• The Rest of MEA Molecular Diagnosis MDx market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 76.73 million in 2024.

Molecular Diagnosis MDx Market Analysis

Molecular Diagnosis MDx Market Type Segment Analysis

According to Cognitive Market Research, NIPT has grown as a high-growth segment in the MDx market due to its potentiality in detecting in the fetus genetic abnormalities by means of a simple blood test from the mother. This non-invasive approach enables high accuracy and sensitivity for chromosomal abnormalities like Down syndrome without invasive procedures like amniocentesis. Its dominance in the MDx market has been significantly contributed to by healthcare providers and expectant parents alike through the wide acceptance of NIPT.

Liquid Biopsy is the fastest-growing segment of the MDx market. Liquid biopsy entails the analysis of circulating tumor cells, cell-free DNA, or exosomes in blood or other body fluids for the diagnosis and monitoring of cancer. Being non-invasive, this technique gives effective information on tumor mutations, treatment response, and course of disease and hence partly replaces the traditional tissue biopsy.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Molecular Diagnosis MDx Industry. Request a Free Sample PDF!

Molecular Diagnosis MDx Market Application Segment Analysis

According to Cognitive Market Research, Oncology holds the largest share of the MDx market due to the increasing demand for molecular diagnostic tests in cancer detection, treatment selection, and monitoring of disease progression. Molecular diagnostics play a very visible role in oncology in assessing tumor genetics that advises targeted therapies and positively impacts patient outcomes. It has been observed that the adoption of molecular diagnostic technologies in oncology has accelerated due to the growing burden of cancer across the world, thus driving this segment to the top of the MDx market.

Infectious diseases are driving the fastest-growing segment of the MDx market. With the growing incidences of infectious diseases, including outbreaks of viral infections like COVID-19, quick and accurate diagnosis presents a challenge. Molecular diagnostics offers a very sensitive and specific method of detection for an infectious agent, thus supporting early diagnosis, treatment decisions, and disease control measures. Due to the increasing management of infectious diseases and new molecular diagnostic assays in the process of development, this segment has grown tremendously in the MDx market.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion